Member Info for carlotowl

Saw the largest single buy I've seen yet on OTC Markets today as well.

Yup. I've been able to sell 765k shares over the advertised bid for 3 days running now if I'd wanted. MM's want shares because they're short of them. Any news around non dilutive funding or a deal of some sort and this will rocket. Hardly any shares in issue and a large amount held by insiders who aren't selling. Now is the time to buy before that news lands.

Lots of things. That near term they're looking to do a deal with an ultra luxury brand for the T-Rex leather and they're speaking to lots of parties. Also in the near term that they will be raising funding at subsidiary level (non dilutive) for LGL and Kerato and that talks stalled briefly cos of the summer holidays. In the New Year they'll be doing a showcase event for the T-Rex leather. That they are looking at ultra premium pricing for any T-Rex products and will scale the rest of the leather business over the coming months and years as funds become available. That they can't make enough leather to satisfy the big fashion houses demands. That lots of parties are interested for different reasons. Some for the strength of it, some for the uniqueness, some for the environmental/social elements. Well worth a listen. Big things to come.

Have a listen to this and your concerns around finding will evaporate. Non dilutive funding incoming and big fashion houses happy to commit funds once they've tested it enough. Also a deal in the ultra luxury space in the 'near term'. Offtake agreement perhaps? https://x.com/RoastPR/status/1963875198106579050?t=jASfMPs6TRoHgNrYAblcCw&s=19

Let me get this straight. Some people have sold because the Chairman who is just a placeholder and has done nothing resigned?! This drop back below 2p is a gift if you've got funds to buy!

It's called profit taking.

Didn't know you held an interest in Avacta Sponge. Good to know and I'm also looking forward to that statement being fleshed out further!

Tis Myles topping up with a couple of hundred thousand shares.

People think you're a joke Hurst. I don't. Let the fun and games begin - tomorrow.

One of these days a big RNS will drop and it'll explode into life. Totally agree GLR, those in the know taking positions prior to this occurring and the herd arriving.

Ref the Subway deal, they are still fulfilling some contractual obligations from the original contract that weren't able to be done because of Covid. Confident a renewal is on the cards, especially after Subway responded to me on Twitter to 'watch this space' ref a renewal.

The hedge is set at 43p a therm for 1.46m therms a month. They will be producing 1.54m therms month in the coming days. So that's £627k rev from the hedge and £320k rev from unhedged production (for now). Once the second compressor comes online it's all market rates which could happen in the next couple of months as they're currently not utilising the full flow rates of the two current wells. If they can take advantage of the full flow rates then they could generate an extra 30k therms daily which would equate to around £3m a month at today's prices. Plus looking further ahead they have the sidetrack that could double production again.

Thanks Charlie.

Other than the annual results on 30th, why do we think all the other news will land in March?

Definitely not worth reading much into. Simple fact remains that all the signs are that AVA6k is working and we await an official update to tell us that, which is due. If it's working, they either licence it for a big upfront fee for non dilutive funding (the plan all along), or they raise at a considerably higher SP than today to be able to fund the pipeline past mid 2023. Either option is good news. All this obviously depends on a good AVA update.

Here's the update doc. No mention of trading update. https://docs.google.com/forms/d/e/1FAIpQLScPO1DbwWepLBCNhlPpiq1_jnaMGYwqzaXD-k_ZmvIft0dBMQ/viewform

Have you only just realised this? That's why when the derampers drip on about needing funding through a placing it is highly unlikely if AVA6000 initial results are good. Not impossible, because it might be they can't secure a large up front licensing deal, but when P1a is complete in Q2 they will know whether it reduces/gets rids of side effects and if it does, that part of the platform is proven and at that point large pharma will know of the huge commercial opportunity and will likely want to be in on the action. Hence either a licensing deal or early moves for a takeover. If the LFT is not going to get us much (or any) revenue then the P1a data is absolutely pivotal.

Well done for bringing some sanity back to this board Poirot. Keep up the good work.

Sorry boys but the whole nucelocapsid bit rules us out save the gov ignoring their own guidelines. A lack of a gov contract has already been priced in thankfully.

Ndn, you clearly weren't listening. He said they continue to test negatives to drive thr decimal point. It's only negatives that they lack for the new govt requirements. Govt deal is still very much on the cards.